Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB00872_nanopub.RABPnBCtzHOQ5nh8yKAoSjedEVBVJD_tsQanm_q7F3bk8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB00872 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB00872 label "DDI between Trazodone and Conivaptan - The CYP3A4 inhibitor, Conivaptan, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Conivaptan is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB00872]" assertion.
- drugbank_resource:DB00656_DB00872 identifier "drugbank_resource:DB00656_DB00872" assertion.
- drugbank_resource:DB00656_DB00872 title "DDI between Trazodone and Conivaptan - The CYP3A4 inhibitor, Conivaptan, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Conivaptan is initiated, discontinued or dose changed." assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00872 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00872 assertion.